Del Rincon, Sonia V

6 records totalling $2,719,076.00 CAD, from official Government of Canada open data.

Embed this chart

By department

Records

Del Rincon, Sonia V $1,090,125.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2025-2026
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercia...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2019-2020
Canada

Support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization; Promote relevant collaborations acro...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Investigator-Initiated Research
FY 2021-2022
Canada

The Project Grant program is expected to: • Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commerc...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2025-2026
Canada

The Operating Grants competition is the principal means by which CRS fulfills its mission to support fundamental, early translational and environment-cancer research on all types of cancer.

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
FY 2020-2021
Canada

The objectives of this funding opportunity are: •To support research in all areas of cancer, including breast cancer, by Early Career Researchers •To support research in the area of non-melanoma ski...

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2018-2019
Canada

ICS - (ICR) Early Career Award in Cancer Research (Prize): Inhibiting the MNK1/2-eIF4E axis, to favor anti-tumor immunity in melanoma.